Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM) today announces that, following receipt of the Dutch investigating centre’s ethics committee approval, it is commencing a clinical study of the effects of its...
The Research Insights added an innovative statistical data of UK Clinical Trial Outsourcing Market. To discover the different aspects of the business, this report uses exploratory techniques, such as primary and secondary research. It provides a valuable source of...
Mount Sinai was part of the largest clinical trial for asthma self-management support in older patients, which resulted in improved control and quality of life, and fewer emergency department visits. Topic: Asthma affects 7 percent of Americans older than 65 and...
– CAROLINA® demonstrated no increased cardiovascular risk for Tradjenta® (linagliptin) versus glimepiride in the only active-comparator cardiovascular outcome trial for a dipeptidyl peptidase-4 (DPP-4) inhibitor – Adults with diabetes treated with...
Lannett Company, Inc. (NYSE: LCI) today announced the commencement of a human clinical trial of biosimilar insulin glargine, a product the company is co-developing with its strategic alliance partners within the HEC Group of companies (HEC). The trial, being...
Total of 96 agitated patients and healthy volunteers have received multiple doses of BXCL501, a proprietary sublingual thin film On track to announce top line results from Phase 2 efficacy trial in 3Q 2019 Planning to initiate first Phase 3 pivotal trial in 4Q 2019...
Email
Text